Microbot Medical (MBOT) Cash from Financing Activities (2010 - 2025)

Microbot Medical has reported Cash from Financing Activities for 13 years, with the latest figure at $2.5 million in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities fell 11.51% year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2025 stood at $86.2 million (up 986.69% YoY), and the FY2025 full-year result was $86.2 million, up 986.69% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at $2.5 million, down from $51.2 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $51.2 million in Q3 2025, with the low at -$161000.0 in Q3 2023.
• Historically, Cash from Financing Activities has averaged $10.4 million across 3 years, with a median of $2.5 million in 2025.
• The largest YoY upside for Cash from Financing Activities was 7984.68% in 2025 against a maximum downside of 11.51% in 2025.
• Microbot Medical's Cash from Financing Activities stood at -$161000.0 in 2023, then surged by 1859.01% to $2.8 million in 2024, then fell by 11.51% to $2.5 million in 2025.
• The last three Cash from Financing Activities figures came in at $2.5 million (Q4 2025), $51.2 million (Q3 2025), and $4.8 million (Q2 2025), per Business Quant data.